Insulet
PODD
#1049
Rank
HK$166.79 B
Marketcap
HK$2,369
Share price
-3.62%
Change (1 day)
13.80%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total debt

Total debt on the balance sheet as of September 2025 : HK$7.89 Billion

According to Insulet's latest financial reports the company's total debt is HK$7.89 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insulet - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$10.80 B-2.26%
2023-12-31HK$11.05 B0.96%
2022-12-31HK$10.95 B10.26%
2021-12-31HK$9.93 B20.96%
2020-12-31HK$8.21 B18.75%
2019-12-31HK$6.91 B49.16%
2018-12-31HK$4.63 B4.8%
2017-12-31HK$4.42 B71.42%
2016-12-31HK$2.58 B87.58%
2015-12-31HK$1.37 B4.53%
2014-12-31HK$1.31 B39.47%
2013-12-31HK$0.94 B3.02%
2012-12-31HK$0.91 B8.64%
2011-12-31HK$0.84 B56.02%
2010-12-31HK$0.54 B-28.14%
2009-12-31HK$0.75 B61.72%
2008-12-31HK$0.46 B123.55%
2007-12-31HK$0.20 B-8.48%
2006-12-31HK$0.22 B199.7%
2005-12-31HK$75.83 M88613.37%
2004-12-31HK$0.08 M0.26%
2003-12-31HK$0.08 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ICU Medical
ICUI
HK$10.61 B 34.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
HK$3.49 B-55.73%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$20.04 B 153.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.36 B 4,412.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$100.70 B 1,175.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$222.62 B 2,719.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$330.77 B 4,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA